Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2009
Published online before print September 10, 2009, doi: 10.1161/CIRCRESAHA.109.197434
A more recent version of this article appeared on October 9, 2009
This Article
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
105/8/775    most recent
CIRCRESAHA.109.197434v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Lamon, B. D.
Right arrow Articles by Nasjletti, A.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lamon, B. D.
Right arrow Articles by Nasjletti, A.
Related Collections
Right arrow Cardiovascular Pharmacology
Right arrow Animal models of human disease
Right arrow Other hypertension
Right arrow Peripheral vascular disease
Right arrow Endothelium/vascular type/nitric oxide
Right arrow Other Vascular biology

Submitted on March 17, 2009
Revised on August 25, 2009
Accepted on August 27, 2009

Dual Pathways of Carbon Monoxide–Mediated Vasoregulation. Modulation by Redox Mechanisms

Brian D. Lamon *; Frank F. Zhang ; Nitin Puri ; Sergey V. Brodsky ; Michael S. Goligorsky ; and Alberto Nasjletti

From the Departments of Pharmacology (B.D.L., F.F.Z., N.P., A.N.) and Medicine (S.V.B., M.S.G.), New York Medical College, Valhalla.

* To whom correspondence should be addressed. E-mail: bdlamon{at}aol.com.

Rationale: Vascular tissues produce carbon monoxide (CO) via HO-dependent and HO-independent mechanisms; the former in tandem with biliverdin and iron and the latter as a lone product. CO has been shown to function as both a vasoconstrictor and vasodilator; however, factors that dictate the vasoregulatory phenotype of this gas are unknown.

Objective: Herein, we demonstrate that CO-mediated vasoconstriction is mechanistically linked to enhanced reactive oxygen species production that masks vasodilatory pathways.

Methods and Results: Sprague–Dawley rat interlobar and interlobular arteries were examined in terms of superoxide (O2·-) generation and vascular reactivity in the absence and presence of antioxidants. Both authentic CO and the CO-releasing molecule (CORM)-3 constricted renal arteries and increased O2·- production in a dose-dependent manner. The antioxidants tempol, ebselen, and deferoxamine inhibited CO-induced O2·- production and converted CO from constrictor to dilator. CO-induced O2·- generation was found to involve the activity of multiple oxidases including nitric oxide synthase, NADPH oxidase, xanthine oxidase, and complex IV of the mitochondrial electron chain. Furthermore, inhibition of these enzymes converted CO from constrictor to dilator. Similarly, biliverdin and bilirubin inhibited CO-induced O2·- production and vasoconstriction, allowing for a vasodilatory response to CO to be expressed. CO-induced vasoconstriction was dependent on a non-thromboxane agonist of the thromboxane receptor, whereas vasodilatory mechanisms of CO relied on the activation of soluble guanylate cyclase and calcium-gated potassium channels.

Conclusions: CO-induced vasoconstriction involves the generation of reactive oxygen species, which, when negated, allows for the expression of vasodilatory pathways which are masked by the primary oxidative stress response to this gas.


Key words: carbon monoxide • vascular reactivity • reactive oxygen species • oxidative stress • antioxidant